Cercar
01/08/2022
A Framework for the Development of Living Practice Guidelines in Health Care.
El Mikati IK, Khabsa J, Harb T, Khamis M, Agarwal A, Pardo-Hernandez H, Farran S, Khamis AM, El Zein O, El-Khoury R, Schünemann HJ, Akl EA, Alonso-Coello P, Alper BS, Amer YS, Arayssi T, Barker JM, Bouakl I, Boutron I, Brignardello-Petersen R, Carandang K, Chang S, Chen Y, Cuker A, El-Jardali F, Florez I, Ford N, Grove J, Guyatt GH, Hazlewood GS, Kredo T, Lamontagne F, Langendam MW, Lewin S, Macdonald H, McFarlane E, Meerpohl J, Munn Z, Murad MH, Mustafa RA, Neumann I, Nieuwlaat R, Nowak A, Pardo JP, Qaseem A, Rada G, Righini M, Rochwerg B, Rojas-Reyes MX, Siegal D, Siemieniuk R, Singh JA, Skoetz N, Sultan S, Synnot A, Tugwell P, Turner A, Turner T, Venkatachalam S, Welch V, Wiercioch W. A Framework for the Development of Living Practice Guidelines in Health Care.. ANNALS OF INTERNAL MEDICINE. 2022; 175(8)DOI:10.7326/M22-0514. PMID:35785533. IF:39.200(Q1/1D).
01/12/2025
Immunotherapy or Targeted Therapy Versus Best Supportive Care for Advanced Gastric Cancer: A Systematic Review and Meta-analysis of Randomized Trials
Meade, A, Santero, M, Savall-Esteve, O, Bracchiglione, J, Leache, L, Selva, A, Macias, I, Cerdà, P, Cosp, XB. Immunotherapy or Targeted Therapy Versus Best Supportive Care for Advanced Gastric Cancer: A Systematic Review and Meta-analysis of Randomized Trials. Journal Of Gastrointestinal Cancer. 2025; 56(1)DOI:10.1007/s12029-024-01155-y. PMID:40032744. IF:(Q/D).
15/11/2025
Desert dust, sandstorms, and infectious diseases: A scoping review
Tobias, A, Chua, PC, Ith, S, Yu, LS, Stafoggia, M, Roque, M, Lwin, KS, Hashizume, M. Desert dust, sandstorms, and infectious diseases: A scoping review. ENVIRONMENTAL RESEARCH. 2025; 285DOI:10.1016/j.envres.2025.122582. PMID:40812701. IF:7.700(Q1/1D).
01/09/2025
E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: A clinicopathological study
Pérez-Barraza, N, Concha, S, Acuna, P, Martín, SS, Córdova, C, Varas, J, Toledo, D, Madrid, E. E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: A clinicopathological study. PATHOLOGY RESEARCH AND PRACTICE. 2025; 273DOI:10.1016/j.prp.2025.156160. PMID:40774061. IF:3.200(Q2/3D).